Baxter Announces U.S. FDA Approval and Launch of Ready-to-use Cardiovascular Medicine Norepinephrine in Premix Formulation

First and only manufacturer-prepared premix formulation of norepinephrine available Offers variety of storage options under refrigeration and at room temperature, allowing drug to be placed closer to patient care settings Ready-to-use format means less chance of compounding errors and touch contamination associated with compounded drug formulations DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International […]

Cardiac Insight Announces Partnership with Lovell Government Services to Extend Distribution Capabilities to U.S. Department of Defense and Veterans Affairs Medical Facilities

Partnership Expands Access to Cardea SOLO™ Digital Health Solution for Early Atrial Fibrillation Detection and Diagnosis to Veterans and Active-Duty Military Personnel BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc.(“Cardiac Insight” or the “Company”) is a US-based healthcare innovator specializing in wearable cardiac sensors and proprietary software that automatically analyzes electrocardiogram (ECG) testing […]

Huadong Medicine and PulseCath Announce Strategic Collaboration to Develop and Commercialize the iVAC mechanical circulatory product in Greater China

Partnership accelerates the development of the iVAC 2L mechanical circulatory device in Greater China. Expands Huadong Medicine’s medical portfolio for cases of high-risk PCI with innovative percutaneous ventricle assist devices based on innovative pulsatile technology. PulseCath will receive a significant investment in its share capital and in payments for regulatory […]

Cardialen Awarded $3 Million Federal Grant to Advance Therapy Designed to Treat Atrial Fibrillation for Improved Heart Failure Outcomes

National Institutes of Health grant will support Cardialen’s development of its implantable, low-energy therapy designed to treat atrial fibrillation, a cardiac arrhythmia associated with debilitating shortness of breath, fatigue, pain, and an increased risk of stroke. MINNEAPOLIS–(BUSINESS WIRE)–Cardialen, Inc., has been awarded a $3 million National Institutes of Health (NIH) […]

Cardiologs’ AI Improves Services for Cardiologists at Three European Medical Centers

Deep learning platform enables healthcare professionals in France to speed the analysis of electrocardiograms (ECGs), reduce wait times, and improve diagnostic capabilities PARIS and BOSTON, Sept. 16, 2021 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, is collaborating with cardiologists at three medical centers in France to strengthen their cardiology services.  Over the […]

VOLTA MEDICAL expands its hospital network in France as part of an international multicenter study with its VX1 artificial intelligence software in cardiology

For the treatment, in the operating room, of atrial fibrillation, the most complex and most common arrhythmia in the world 11 French research centers have already joined the study in 2021 The first results will be published in Q3 2023 MARSEILLE, France – ( BUSINESS WIRE ) – Volta Medical, an innovative […]

Qardio announces the first Remote Patient Monitoring system to include a Cardiac monitoring service in a single, intuitive platform.

SAN FRANCISCO, Sept. 14, 2021 /PRNewswire/ — Qardio, Inc. announced today the launch of the first ever fully remote end-to-end RPM service to include cardiac arrhythmia analysis. QardioDirect (Qardio’s all-inclusive service for RPM) now includes ambulatory Cardiac monitoring to help diagnose atrial fibrillation along with a large range of other arrhythmias. Multiple […]

CardioFocus Announces Agreement to Acquire Intellectual Property

MARLBOROUGH, Mass., September 14, 2021 – CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced today that it has entered into an agreement with IsoLase Ltd. to acquire IsoLase’s patent portfolio. The acquisition agreement includes US patents 8,992,514 and 10,517,669 and EU patent […]

BioSig Increases Installation Footprint Adding St. Elizabeth’s Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System

The Company expands into exploration of its novel signal processing technology in physiologic pacing procedures Westport, CT, Sept. 13, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the […]